Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig T Jordan

Showing results (81-90 of 164) with videos related to

Pageof 17
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 9, 2024
MYC Inhibition Potentiates CD8+ T Cells Against Multiple Myeloma and Overcomes Immunomodulatory Drug ResistanceLorraine N Davis, Zachary J Walker, Lauren T Reiman, et al.
European Journal of Medicinal Chemistry|July 6, 2021
Antitumor properties of novel sesquiterpene lactone analogs as NFκB inhibitors that bind to the IKKβ ubiquitin-like domain (ULD)Narsimha R Penthala, Meenakshisundaram Balasubramaniam, Soma Shekar Dachavaram, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 20, 2020
Delivery of a model lipophilic membrane cargo to bone marrow via cell-derived microparticlesChunyan Yang, Fangfang Chen, Ping Ren, et al.
Molecular Cancer Therapeutics|June 29, 2017
A Small-Molecule Inhibitor of WEE1, AZD1775, Synergizes with Olaparib by Impairing Homologous Recombination and Enhancing DNA Damage and Apoptosis in Acute LeukemiaTamara B Garcia, Jonathan C Snedeker, Dmitry Baturin, et al.
Leukemia & Lymphoma|December 30, 2020
The propriety of upgrading responses to venetoclax + azacitidine in newly diagnosed patients with acute myeloid leukemiaDiana Abbott, Evan Cherry, Maria Amaya, et al.
Blood|September 4, 2009
In vivo prostaglandin E2 treatment alters the bone marrow microenvironment and preferentially expands short-term hematopoietic stem cellsBenjamin J Frisch, Rebecca L Porter, Benjamin J Gigliotti, et al.
Blood|July 3, 2007
Leukemia stem cells in a genetically defined murine model of blast-crisis CMLSarah J Neering, Timothy Bushnell, Selcuk Sozer, et al.
Cancer Research|May 30, 2014
Selenium suppresses leukemia through the action of endogenous eicosanoidsUjjawal H Gandhi, Naveen Kaushal, Shailaja Hegde, et al.
Plos One|December 4, 2009
Modulation of cell surface protein free thiols: a potential novel mechanism of action of the sesquiterpene lactone parthenolideJolanta Skalska, Paul S Brookes, Sergiy M Nadtochiy, et al.
Blood|October 5, 2010
Chemical genomic screening reveals synergism between parthenolide and inhibitors of the PI-3 kinase and mTOR pathwaysDuane C Hassane, Siddhartha Sen, Mohammad Minhajuddin, et al.
Pageof 17

Showing results (81-90 of 164) with videos related to

Sort By:
Pageof 17
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 9, 2024
MYC Inhibition Potentiates CD8+ T Cells Against Multiple Myeloma and Overcomes Immunomodulatory Drug ResistanceLorraine N Davis, Zachary J Walker, Lauren T Reiman, et al.
European Journal of Medicinal Chemistry|July 6, 2021
Antitumor properties of novel sesquiterpene lactone analogs as NFκB inhibitors that bind to the IKKβ ubiquitin-like domain (ULD)Narsimha R Penthala, Meenakshisundaram Balasubramaniam, Soma Shekar Dachavaram, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 20, 2020
Delivery of a model lipophilic membrane cargo to bone marrow via cell-derived microparticlesChunyan Yang, Fangfang Chen, Ping Ren, et al.
Molecular Cancer Therapeutics|June 29, 2017
A Small-Molecule Inhibitor of WEE1, AZD1775, Synergizes with Olaparib by Impairing Homologous Recombination and Enhancing DNA Damage and Apoptosis in Acute LeukemiaTamara B Garcia, Jonathan C Snedeker, Dmitry Baturin, et al.
Leukemia & Lymphoma|December 30, 2020
The propriety of upgrading responses to venetoclax + azacitidine in newly diagnosed patients with acute myeloid leukemiaDiana Abbott, Evan Cherry, Maria Amaya, et al.
Blood|September 4, 2009
In vivo prostaglandin E2 treatment alters the bone marrow microenvironment and preferentially expands short-term hematopoietic stem cellsBenjamin J Frisch, Rebecca L Porter, Benjamin J Gigliotti, et al.
Blood|July 3, 2007
Leukemia stem cells in a genetically defined murine model of blast-crisis CMLSarah J Neering, Timothy Bushnell, Selcuk Sozer, et al.
Cancer Research|May 30, 2014
Selenium suppresses leukemia through the action of endogenous eicosanoidsUjjawal H Gandhi, Naveen Kaushal, Shailaja Hegde, et al.
Plos One|December 4, 2009
Modulation of cell surface protein free thiols: a potential novel mechanism of action of the sesquiterpene lactone parthenolideJolanta Skalska, Paul S Brookes, Sergiy M Nadtochiy, et al.
Blood|October 5, 2010
Chemical genomic screening reveals synergism between parthenolide and inhibitors of the PI-3 kinase and mTOR pathwaysDuane C Hassane, Siddhartha Sen, Mohammad Minhajuddin, et al.
Pageof 17